Figure 1.
![Anti-CMV T-cell activity and clinical response in patients treated with CMV-specific VSTs for active CMV infection. (A) Anti-CMV antigen (phosphoprotein 65 [PP65], immediate early protein-1 [IE1]) T-cell response of the CMV-specific VST products as detected by IFN-γ ELISpot assay. Anti-CMV antigen T-cell response and CMV viral load (IU or copies per milliliter) in the recipient PB post-VST infusion for patient P4, P5, P7 treated with CMV infection (B-D) and timing of concomitant standard antiviral treatment. PCR, polymerase chain reaction; SFU, spot forming units.](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/7/10/10.1182_bloodadvances.2022008219/1/blooda_adv-2022-008219-gr1.jpeg?Expires=1735484381&Signature=YIArQM5z~vXEHSEGhxNS694YicJBubp4eu1AEYeG3ccW9ax4cU~CkYrqwAvY0wCaW~l74VTgvRVFvkvB1dADhjz7wr6V5UFTF2PnbEHEEmK7MspzHacYO2KDJoksp4q43gbsW85N8noAllGiW4M5Fu-3FXAGTnNAAJSykmzJ8sA7ZJfUj4T14SCstJyeBh5MweBWGsX2WkcctZpsMMzCaxA3GdhXQ~ht49Pu7qxtjOl9yjHT4-kunZNoJq5HjHG7tYFlTVXsPA-~LrGCWA9lp9nPeyMQpdcc5PeS2Di3OpxwbXC2sLUm651xDESKpmNI2llEWgIfw16Aila9relCSw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Anti-CMV T-cell activity and clinical response in patients treated with CMV-specific VSTs for active CMV infection. (A) Anti-CMV antigen (phosphoprotein 65 [PP65], immediate early protein-1 [IE1]) T-cell response of the CMV-specific VST products as detected by IFN-γ ELISpot assay. Anti-CMV antigen T-cell response and CMV viral load (IU or copies per milliliter) in the recipient PB post-VST infusion for patient P4, P5, P7 treated with CMV infection (B-D) and timing of concomitant standard antiviral treatment. PCR, polymerase chain reaction; SFU, spot forming units.
